vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Safehold Inc. (SAFE). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $97.9M, roughly 1.3× Safehold Inc.). Safehold Inc. runs the higher net margin — 28.5% vs 3.3%, a 25.2% gap on every dollar of revenue. On growth, Safehold Inc. posted the faster year-over-year revenue change (6.5% vs 4.7%). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 2.5%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
SAFE Investment Company Limited is a Chinese sovereign wealth fund based in Hong Kong.
NATR vs SAFE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $97.9M |
| Net Profit | $4.1M | $27.9M |
| Gross Margin | 72.5% | 98.6% |
| Operating Margin | 4.3% | 27.4% |
| Net Margin | 3.3% | 28.5% |
| Revenue YoY | 4.7% | 6.5% |
| Net Profit YoY | 1379.4% | 7.1% |
| EPS (diluted) | $0.23 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $97.9M | ||
| Q3 25 | $128.3M | $96.2M | ||
| Q2 25 | $114.8M | $93.8M | ||
| Q1 25 | $113.2M | $97.7M | ||
| Q4 24 | $118.2M | $91.9M | ||
| Q3 24 | $114.6M | $90.7M | ||
| Q2 24 | $110.6M | $89.9M | ||
| Q1 24 | $111.0M | $93.2M |
| Q4 25 | $4.1M | $27.9M | ||
| Q3 25 | $5.3M | $29.3M | ||
| Q2 25 | $5.3M | $27.9M | ||
| Q1 25 | $4.7M | $29.4M | ||
| Q4 24 | $-321.0K | $26.0M | ||
| Q3 24 | $4.3M | $19.3M | ||
| Q2 24 | $1.3M | $29.7M | ||
| Q1 24 | $2.3M | $30.7M |
| Q4 25 | 72.5% | 98.6% | ||
| Q3 25 | 73.3% | 98.5% | ||
| Q2 25 | 71.7% | 99.1% | ||
| Q1 25 | 72.1% | 98.8% | ||
| Q4 24 | 72.0% | 98.8% | ||
| Q3 24 | 71.3% | 98.8% | ||
| Q2 24 | 71.4% | 98.8% | ||
| Q1 24 | 71.2% | 98.8% |
| Q4 25 | 4.3% | 27.4% | ||
| Q3 25 | 7.0% | 25.9% | ||
| Q2 25 | 3.7% | 25.5% | ||
| Q1 25 | 5.4% | 25.9% | ||
| Q4 24 | 3.8% | 24.6% | ||
| Q3 24 | 4.6% | 17.5% | ||
| Q2 24 | 5.1% | 26.7% | ||
| Q1 24 | 4.2% | 26.4% |
| Q4 25 | 3.3% | 28.5% | ||
| Q3 25 | 4.2% | 30.5% | ||
| Q2 25 | 4.6% | 29.8% | ||
| Q1 25 | 4.2% | 30.1% | ||
| Q4 24 | -0.3% | 28.3% | ||
| Q3 24 | 3.8% | 21.3% | ||
| Q2 24 | 1.2% | 33.0% | ||
| Q1 24 | 2.1% | 33.0% |
| Q4 25 | $0.23 | $0.38 | ||
| Q3 25 | $0.30 | $0.41 | ||
| Q2 25 | $0.28 | $0.39 | ||
| Q1 25 | $0.25 | $0.41 | ||
| Q4 24 | $-0.02 | $0.36 | ||
| Q3 24 | $0.23 | $0.27 | ||
| Q2 24 | $0.07 | $0.42 | ||
| Q1 24 | $0.12 | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $21.7M |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $161.6M | $2.4B |
| Total Assets | $261.1M | $7.2B |
| Debt / EquityLower = less leverage | — | 1.90× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $21.7M | ||
| Q3 25 | $95.6M | $12.1M | ||
| Q2 25 | $81.3M | $13.9M | ||
| Q1 25 | $86.5M | $17.3M | ||
| Q4 24 | $84.7M | $8.3M | ||
| Q3 24 | $78.7M | $15.6M | ||
| Q2 24 | $68.7M | $13.4M | ||
| Q1 24 | $77.8M | $11.3M |
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.4B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.2B | ||
| Q1 24 | $2.1M | $4.1B |
| Q4 25 | $161.6M | $2.4B | ||
| Q3 25 | $166.7M | $2.4B | ||
| Q2 25 | $163.7M | $2.4B | ||
| Q1 25 | $167.1M | $2.4B | ||
| Q4 24 | $161.0M | $2.3B | ||
| Q3 24 | $162.6M | $2.3B | ||
| Q2 24 | $156.4M | $2.3B | ||
| Q1 24 | $159.7M | $2.3B |
| Q4 25 | $261.1M | $7.2B | ||
| Q3 25 | $264.8M | $7.1B | ||
| Q2 25 | $254.9M | $7.1B | ||
| Q1 25 | $252.7M | $6.9B | ||
| Q4 24 | $240.9M | $6.9B | ||
| Q3 24 | $245.3M | $6.8B | ||
| Q2 24 | $235.8M | $6.8B | ||
| Q1 24 | $247.3M | $6.7B |
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.89× | ||
| Q2 25 | — | 1.87× | ||
| Q1 25 | — | 1.85× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.88× | ||
| Q2 24 | — | 1.81× | ||
| Q1 24 | 0.01× | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $47.8M |
| Free Cash FlowOCF − Capex | $7.6M | — |
| FCF MarginFCF / Revenue | 6.1% | — |
| Capex IntensityCapex / Revenue | 1.9% | — |
| Cash ConversionOCF / Net Profit | 2.41× | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $47.8M | ||
| Q3 25 | $18.5M | $-1.4M | ||
| Q2 25 | $4.3M | $28.0M | ||
| Q1 25 | $2.6M | $8.9M | ||
| Q4 24 | $12.2M | $37.9M | ||
| Q3 24 | $9.6M | $8.3M | ||
| Q2 24 | $1.3M | $24.8M | ||
| Q1 24 | $2.2M | $-3.1M |
| Q4 25 | $7.6M | — | ||
| Q3 25 | $16.8M | — | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-1.5M | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | -1.9% | — | ||
| Q1 24 | -1.4% | — |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.3% | — |
| Q4 25 | 2.41× | 1.72× | ||
| Q3 25 | 3.46× | -0.05× | ||
| Q2 25 | 0.81× | 1.00× | ||
| Q1 25 | 0.55× | 0.30× | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | 2.21× | 0.43× | ||
| Q2 24 | 0.97× | 0.83× | ||
| Q1 24 | 0.94× | -0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
SAFE
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $60.3M | 62% |
| Other | $33.7M | 34% |
| Stabilized Properties | $3.8M | 4% |
